Börse von finanzen.net | Aktien-Nachrichten | Marktberichte

DAX	6.693	-1,4%	Dow	12.801	-0,7%	Euro	1,3200	-0,7%
ESt50	2.481	-1,7%	Nas	2.904	-0,8%	Öl	117,6	-0,9%
TDax	769,9	-0,4%	Nikkei	8.947	-0,6%	Gold	1.721	-0,5%

Albany Molecular Research Aktie [WKN: 918849 / ISIN: US0124231095]

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Depot
Times + Sales	Chart-Analyse	Analysen	Dividende/HV	Profil	Optionsscheine	Watchlist
Börsenplätze	Chartvergleich	Kursziele		Insidertrades	Knock-outs	myfinanzen
Orderbuch	Realtime Stuttgart	RSS Feed		im Forum	Fonds	Senden
Historisch	Realtime Push			IR-Daten	Anleihen	handeln

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

handeln

23.03.10	AMRI Files Motion for Preliminary Injunction Prohibiting Dr. Reddy’s from Distributing Generic Allegra-D® 24
18.02.10	AMRI übernimmt Excelsyn Ltd.
18.02.10	AMRI Acquires Excelsyn Ltd.
08.02.10	AMRI Announces Fourth Quarter 2009 Results
02.02.10	AMRI CFO to Present at UBS 20th Annual Global Healthcare Services Conference
01.02.10	AMRI to Announce Fourth Quarter Results
19.01.10	AMRI CFO to Present at Jefferies 2010 Global Healthcare Services Conference
19.01.10	AMRI Receives SafeBridge® Potent Compound Safety Certification
07.01.10	AMRI CEO to Present at 28th Annual J.P. Morgan Healthcare Conference
09.11.09	AMRI Announces Third Quarter 2009 Results

02.11.09	Third Compound from AMRI Bristol-Myers Squibb Collaboration Selected for Preclinical Development
30.10.09	AMRI to Present at the Oppenheimer 20th Annual Healthcare Conference
26.10.09	AMRI to Announce Third Quarter Results
22.09.09	Governor Christine Gregoire Officially Dedicates New AMRI Research Facility in Bothell, Washington
16.09.09	AMRI CFO to Present at UBS 2009 Global Life Sciences Conference
15.09.09	AMRI Files New Patent Infringement Lawsuits against Dr. Reddy’s Laboratories and Sandoz
04.08.09	AMRI Announces Second Quarter 2009 Results
29.07.09	AMRI to Announce Second Quarter Results
22.06.09	AMRI Opens New Research Facility in Budapest, Hungary
15.06.09	AMRI Announces Changes in India Operations
10.06.09	AMRI to Present at Jefferies 3rd Annual Healthcare Conference
02.06.09	AMRI Advances New Obesity Treatment Toward IND Submission
26.05.09	Phase I Testing to Commence on Second Compound Developed from AMRI, Bristol-Myers Squibb Collaboration
12.05.09	AMRI CFO to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
06.05.09	AMRI Announces First Quarter 2009 Results
06.05.09	AMRI to Present at Bank of America and Merrill Lynch 2009 Healthcare Conference
29.04.09	AMRI Commences Drug Discovery Collaboration with CHDI
23.04.09	AMRI to Announce First Quarter Results
23.04.09	AMRI to Announce First Quarter Results
20.04.09	AMRI Relocates Bothell R&D Facility
03.03.09	AMRI Announces Promotion for CFO Mark T. Frost
09.02.09	AMRI Announces Fourth Quarter 2008 Results
05.02.09	AMRI to Present at UBS 2009 Global Healthcare Services Conference
03.02.09	ADDING MULTIMEDIA AMRI Appoints New General Manager of Large Scale Manufacturing
03.02.09	AMRI Appoints New General Manager of Large Scale Manufacturing
02.02.09	AMRI to Announce Fourth Quarter Results
26.01.09	AMRI Appoints Director of Global Project Management
12.01.09	AMRI Names Senior Director, Analytical and Quality Services
08.01.09	AMRI to Present at 27th Annual J.P. Morgan Healthcare Conference
19.11.08	AMRI Announces Agreement with Teva Pharmaceuticals and Barr Laboratories to Settle Litigation in ALLEGRA® and ALLEGRA®D-12 U.S. Patent Dispute

Finanzen.net

Albany Molecular Research Aktie [WKN: 918849 / ISIN: US0124231095]

Hinweis

Newssuche

ALLE Nachrichten zur Albany Molecular Research Inc.

Anzeige

ANZEIGE